MAPT and Alzheimer disease: By coupling amyloid and tau PET imaging in a clinically homogeneous cohort of 36 patients with ASHT, we aimed to identify AD and SNAP patients according to their molecular signatures and investigate their clinical and imaging trajectories after 2 years of follow-up.